November 13, 2023 — Ultromics, a leading health technology company at the forefront of detection of heart failure and its phenotypes, announces a significant development regarding the reimbursement code for its flagship product,Â
November 11, 2023 — Results of a randomized trial presented today at the American Heart Association’s Scientific Sessions 2023 (AHA 2023), which compared the effects of high-sodium and low-sodium diets on blood pressure in adults, found that following a low-sodium diet significantly lowered blood pressure in 70%-
November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for the treatment of iliac arterial occlusive disease. In March 2023, the iCast covered stent received premarket approval from the U.S. Food and Drug Administration (FDA) for the treatment of iliac arterial occlusive disease. Lower extremity peripheral artery disease (PAD) is estimated to affect approximately 8.5 million people in the U.S.
November 10, 2023 — Silence Therapeutics plc, an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, announced positive topline results from the multiple dose component of the APOLLO phase 1 study of z
November 10, 2023 — Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai will unveil research and clinical insights during the American Heart Association (AHA) Scientific Sessions Nov. 11-13 in Philadelphia.Â
November 10, 2023 — BiVACOR, a clinical-stage medical device company developing the Total Artificial Heart (TAH), has announced that Jordan Ford, Mechanical Engineer at BiVACOR, recently won the Sezai Award, sponsored by Professor Y. Sezai of Nihon University, which is awarded to the individual who contributes to the most innovative paper.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and performing measurements and calculations. The system documents procedure and patient data, and interfaces with other systems and devices before, during, and after procedures.
November 9, 2023 — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the last of four Late-Breaking Clinical Trial sessions at theÂ